1. Wang, Rongrong, Li, Miao, Bai, Yujia, Jiao, Yang, Qi, Xiaofei. 2022. CALCRL Gene is a Suitable Prognostic Factor in AML/ETO+ AML Patients. In Journal of oncology, 2022, 3024360. doi:10.1155/2022/3024360. https://pubmed.ncbi.nlm.nih.gov/35342399/
2. Hou, Yu, Sun, Linyu, LaFleur, Martin W, Sharpe, Arlene H, Kuchroo, Vijay K. 2024. Neuropeptide signalling orchestrates T cell differentiation. In Nature, 635, 444-452. doi:10.1038/s41586-024-08049-w. https://pubmed.ncbi.nlm.nih.gov/39415015/
3. Grandits, Alexander M, Wieser, Rotraud. 2021. Gene expression changes contribute to stemness and therapy resistance of relapsed acute myeloid leukemia: roles of SOCS2, CALCRL, MTSS1, and KDM6A. In Experimental hematology, 99, 1-11. doi:10.1016/j.exphem.2021.05.004. https://pubmed.ncbi.nlm.nih.gov/34029637/
4. Gong, Yao, Wei, Jiang-Ping, Wang, Tim Hua, Zhong, Hong-Bing, Liao, Xin-Hua. . Calcitonin gene-related peptide receptor Calcrl is enriched in hair follicles stem cells and differentially expressed in interfollicular epidermis in murine skin. In Neuroreport, 31, 814-818. doi:10.1097/WNR.0000000000001497. https://pubmed.ncbi.nlm.nih.gov/32576770/